A Comparative Study of Efficacy and Adverse-Effects of New Anti-Psychotic Lurasidone with Olanzapine, Quitiapine and Risperidone in Patients of Schizophrenia

Simple item page
dc.contributor.authorKataria, Shivien_US
dc.contributor.authorParmar, Seema Singhen_US
dc.date.accessioned2020-09-24T07:26:46Z
dc.date.available2020-09-24T07:26:46Z
dc.date.issued2020-01
dc.description.abstractIntroduction: Schizophrenia is a debilitating disorder, whichhas affected the lives of the diseased & the people aroundthem in troublesome. New interventions are made regularly forthe best outcomes from the available treatments. Aim of thestudy of to compare the efficacy & side-effect profile of the newdrug-Lurasidone with other atypical anti-psychoticsolanzapine, risperidone & quitiapine.Materials & Methods: The presented study was conductedover the duration of 15 months (January 2018- March 2019).This study comprises of 100 subjects, who were divided in 4groups & drugs were randomly provided to them (25 each).Subjects were evaluated using various instruments.Results: It was found that the efficacy of Lurasidone wasalmost similar to other drugs, although scoring better withPANSS & BPRS. Metabolic changes i.e., serum cholesterol,serum LDL, HDL, VLDL levels were found greater in otherdrugs as compared to lurasidone. Fasting glucose levels andweight gain were found to be increased in drugs especiallyolanzapine when compared with lurasidone.en_US
dc.identifier.affiliationsPG Resident (IIIrd Year), Teerthanker Mahaveer Medical College & Research Centre, Moradabad, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsAssociate Professor, Department of Psychiatry, Teerthanker Mahaveer Medical College & Research Centre, Moradabad, Uttar Pradesh, India.en_US
dc.identifier.citationKataria Shivi, Parmar Seema Singh. A Comparative Study of Efficacy and Adverse-Effects of New Anti-Psychotic Lurasidone with Olanzapine, Quitiapine and Risperidone in Patients of Schizophrenia. International Journal of Medical Research Professionals. 2020 Jan; 6(1): 206-208en_US
dc.identifier.issn2454-6364
dc.identifier.issn2454-6356
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/203554
dc.languageenen_US
dc.publisherIbn Sina Academy of Medieval Medicine & Sciencesen_US
dc.relation.issuenumber1en_US
dc.relation.volume6en_US
dc.source.urihttps://dx.doi.org//10..21276/ijmrp.2020.6.1.049en_US
dc.subjectSchizophreniaen_US
dc.subjectLurasidoneen_US
dc.subjectAdverse Effects.en_US
dc.titleA Comparative Study of Efficacy and Adverse-Effects of New Anti-Psychotic Lurasidone with Olanzapine, Quitiapine and Risperidone in Patients of Schizophreniaen_US
dc.typeJournal Articleen_US
Files
Collections
International Journal of Medical Research Professionals